{"title":"Evolution of SARS-CoV-2-specific CD4<sup>+</sup> T cell epitopes.","authors":"Marina Brand, Can Keşmir","doi":"10.1007/s00251-023-01295-8","DOIUrl":null,"url":null,"abstract":"<p><p>Vaccination clearly decreases coronavirus disease 2019 (COVID-19) mortality; however, they also impose selection pressure on the virus, which promotes the evolution of immune escape variants. For example, despite the high vaccination level in especially Western countries, the Omicron variant caused millions of breakthrough infections, suggesting that the highly mutated spike protein in the Omicron variant can escape antibody immunity much more efficiently than the other variants of concern (VOCs). In this study, we investigated the resistance/susceptibility of T helper cell responses that are necessary for generating efficient long-lasting antibody immunity, in several VOCs. By predicting T helper cell epitopes on the spike protein for most common HLA-DRB1 alleles worldwide, we found that although most of high frequency HLA-DRB1 alleles have several potential T helper cell epitopes, few alleles like HLA-DRB1 13:01 and 11:01 are not predicted to have any significant T helper cell responses after vaccination. Using these predictions, a population based on realistic human leukocyte antigen-II (HLA-II) frequencies were simulated to visualize the T helper cell immunity on the population level. While a small fraction of this population had alarmingly little predicted CD4 T cell epitopes, the majority had several epitopes that should be enough to generate efficient B cell responses. Moreover, we show that VOC spike mutations hardly affect T helper epitopes and mainly occur in other residues of the spike protein. These results suggest that lack of long-lasting antibody responses is not likely due to loss of T helper cell epitopes in new VOCs.</p>","PeriodicalId":13446,"journal":{"name":"Immunogenetics","volume":"75 3","pages":"283-293"},"PeriodicalIF":2.9000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887569/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunogenetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00251-023-01295-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 3
Abstract
Vaccination clearly decreases coronavirus disease 2019 (COVID-19) mortality; however, they also impose selection pressure on the virus, which promotes the evolution of immune escape variants. For example, despite the high vaccination level in especially Western countries, the Omicron variant caused millions of breakthrough infections, suggesting that the highly mutated spike protein in the Omicron variant can escape antibody immunity much more efficiently than the other variants of concern (VOCs). In this study, we investigated the resistance/susceptibility of T helper cell responses that are necessary for generating efficient long-lasting antibody immunity, in several VOCs. By predicting T helper cell epitopes on the spike protein for most common HLA-DRB1 alleles worldwide, we found that although most of high frequency HLA-DRB1 alleles have several potential T helper cell epitopes, few alleles like HLA-DRB1 13:01 and 11:01 are not predicted to have any significant T helper cell responses after vaccination. Using these predictions, a population based on realistic human leukocyte antigen-II (HLA-II) frequencies were simulated to visualize the T helper cell immunity on the population level. While a small fraction of this population had alarmingly little predicted CD4 T cell epitopes, the majority had several epitopes that should be enough to generate efficient B cell responses. Moreover, we show that VOC spike mutations hardly affect T helper epitopes and mainly occur in other residues of the spike protein. These results suggest that lack of long-lasting antibody responses is not likely due to loss of T helper cell epitopes in new VOCs.
疫苗接种明显降低2019冠状病毒病(COVID-19)死亡率;然而,它们也对病毒施加了选择压力,这促进了免疫逃逸变异的进化。例如,尽管特别是西方国家的疫苗接种水平很高,但Omicron变体引起了数百万例突破性感染,这表明Omicron变体中高度突变的刺突蛋白可以比其他相关变体(VOCs)更有效地逃避抗体免疫。在这项研究中,我们研究了在几种挥发性有机化合物中产生有效持久抗体免疫所必需的T辅助细胞反应的抗性/易感性。通过预测世界上最常见的HLA-DRB1等位基因刺突蛋白上的T辅助细胞表位,我们发现尽管大多数高频HLA-DRB1等位基因有几个潜在的T辅助细胞表位,但少数等位基因如HLA-DRB1 13:01和11:01在接种后没有预测任何显著的T辅助细胞应答。利用这些预测,模拟了一个基于现实人类白细胞抗原- ii (HLA-II)频率的群体,以可视化群体水平上的T辅助细胞免疫。虽然一小部分人的CD4 T细胞表位少得惊人,但大多数人有几个表位,应该足以产生有效的B细胞反应。此外,我们发现VOC刺突突变几乎不影响T辅助表位,主要发生在刺突蛋白的其他残基上。这些结果表明,在新的VOCs中,缺乏持久的抗体反应不太可能是由于辅助性T细胞表位的丢失。
期刊介绍:
Immunogenetics publishes original papers, brief communications, and reviews on research in the following areas: genetics and evolution of the immune system; genetic control of immune response and disease susceptibility; bioinformatics of the immune system; structure of immunologically important molecules; and immunogenetics of reproductive biology, tissue differentiation, and development.